{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:34:42Z","timestamp":1786649682721,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The purpose of this study is to retrospectively compare the therapeutic efficacy and safety of single session microwave ablation (MWA) and multiple session MWA for multiple malignant lung tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Retrospective analysis was conducted on clinical and pathological data of 103 patients with such malignancies treated from January 2020 to December 2022. Patients were categorized based on the number of MWA sessions required. Patients who had received only one MWA treatment were included in the single session MWA group, and patients, who had received two or more MWA treatments were included in the multiple session MWA group. Chest-enhanced CT scans were performed at 1, 3, 6, and 12 months post-MWA to assess ablation outcomes. The primary focus was the median overall survival (mOS), while secondary endpoints encompassed median local progression-free survival (PFS), technical success rates, safety, and complication rate. Analysis was performed by log-rank test and Cox proportional hazard regression model, using the Common Terminology Standard for Adverse Events (version 5.0) to assess safety within 28 days after MWA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of 103 patients with multiple malignant lung tumors, each undergoing at least two tumor treatments during 168 MWA sessions. The median OS for the entire cohort stood at 27 months, with a corresponding median local PFS of 26 months. Patients in the single session MWA group had a median OS of 33 months compared with 13.1 months for those in the multiple session group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001). Notably, adverse factors affecting survival after adjusting for confounding variables included T stage (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002), comorbidity (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.018), solid tumor interior environment (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.043), and multiple session MWA sessions (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.035). No produce-related deaths or grade 3 or 4 adverse events occurred, with pneumothorax being the most common complication (13.1%). There is no significant difference in the occurrence of complications between the two groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). Additionally, single session MWA exhibited superior OS and local PFS compared to multiple session MWA sessions, with statistically significant differences.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>For multiple session lung malignant tumors, the single session MWA group is superior to MWA in terms of survival and local tumor control, with no statistically significant difference in the incidence of complications between the two groups. The findings suggest that single session MWA procedures might be advantageous over multiple session MWAs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1047_24","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:00:31Z","timestamp":1767189631000},"page":"1170-1178","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A comparison of single session and multiple session microwave ablation for multiple lung malignancies"],"prefix":"10.4103","volume":"21","author":[{"given":"Bohan","family":"Song","sequence":"first","affiliation":[{"name":"Department of Minimally Invasive Intervention, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Intervention, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Lei","sequence":"additional","affiliation":[{"name":"Yunnan Provincial Key Laboratory of Public Health and Biosafety and School of Public Health, Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Intervention, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinshan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Intervention, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijie","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Intervention, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Intervention, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Intervention, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongying","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Intervention, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Yanshan County People\u2019s Hospital, Yanshan, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Intervention, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"R1-20260102","first-page":"209","article-title":"Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"(Electronic Suppl 1)","key":"R2-20260102","doi-asserted-by":"crossref","first-page":"eS17","DOI":"10.3949\/ccjm.79.s2.04","article-title":"Preoperative evaluation of the lung resection candidate","volume":"79","author":"Mazzone","year":"2012","journal-title":"Cleve Clin J Med"},{"key":"R3-20260102","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/1754-9485.12068","article-title":"High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer:A preliminary study","volume":"57","author":"Liu","year":"2013","journal-title":"J Med Imaging Radiat Oncol"},{"key":"R4-20260102","doi-asserted-by":"crossref","first-page":"590","DOI":"10.21037\/jtd.2017.03.14","article-title":"Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation","volume":"9","author":"Zhong","year":"2017","journal-title":"J Thorac Dis"},{"key":"R5-20260102","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.diii.2019.07.008","article-title":"Percutaneous thermal ablation of primary and secondary lung tumors:Comparison between microwave and radiofrequency ablation","volume":"100","author":"Aufranc","year":"2019","journal-title":"Diagn Interv Imaging"},{"key":"R6-20260102","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1148\/radiol.2020191272","article-title":"Three-year survival rate after radiofrequency ablation for surgically resectable colorectal lung metastases:A prospective multicenter study","volume":"294","author":"Hasegawa","year":"2020","journal-title":"Radiology"},{"key":"R7-20260102","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","article-title":"Using the common terminology criteria for adverse events (CTCAE-Version 5.0) to evaluate the severity of adverse events of anticancer therapies","volume":"112","author":"Freites-Martinez","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"R8-20260102","first-page":"455","article-title":"[Clinical diagnosis and treatment of multiple pulmonary nodules","volume":"45","author":"Zhong","year":"2023","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"R9-20260102","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.4103\/jcrt.jcrt_898_24","article-title":"Microwave ablation after VATS in patients with multiple pulmonary nodules","volume":"20","author":"Cui","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R10-20260102","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4103\/jcrt.jcrt_2418_24","article-title":"Microwave ablation combined with third-generation epidermal growth factor receptor-tyrosine kinase inhibitor treatment in EGFR-mutant advanced non-small cell lung cancer","volume":"21","author":"Chen","year":"2025","journal-title":"J Cancer Res Ther"},{"key":"R11-20260102","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4103\/jcrt.jcrt_2479_24","article-title":"A major complication of microwave ablation in a patient with surgically treated ground-glass opacity","volume":"21","author":"Xu","year":"2025","journal-title":"J Cancer Res Ther"},{"key":"R12-20260102","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.4103\/jcrt.jcrt_2048_23","article-title":"Changes in the pulmonary function of CT-guided microwave ablation for patients with malignant lung tumors","volume":"19","author":"Li","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R13-20260102","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/resp.14315","article-title":"Current trends in image-guided chest interventions","volume":"27","author":"Lau","year":"2022","journal-title":"Respirology"},{"key":"R14-20260102","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.21037\/jtd-2019-cptn-08","article-title":"Image guided thermal ablation in lung cancer treatment","volume":"12","author":"Lin","year":"2020","journal-title":"J Thorac Dis"},{"key":"R15-20260102","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1055\/s-0043-109010","article-title":"Thermal ablation of lung tumors:Focus on microwave ablation","volume":"189","author":"Vogl","year":"2017","journal-title":"Rofo"},{"key":"R16-20260102","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/02656736.2020.1756467","article-title":"A feasibility and safety study of computed tomography-guided percutaneous microwave ablation:A novel therapy for multiple synchronous ground-glass opacities of the lung","volume":"37","author":"Huang","year":"2020","journal-title":"Int J Hyperthermia"},{"key":"R17-20260102","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00330-020-07299-2","article-title":"Standardizing percutaneous microwave ablation in the treatment of lung tumors:A prospective multicenter trial (MALT study)","volume":"31","author":"Iezzi","year":"2021","journal-title":"Eur Radiol"},{"key":"R18-20260102","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/02656736.2017.1366553","article-title":"The safety and efficacy of microwave ablation for the treatment of CRC pulmonary metastases","volume":"34","author":"Cheng","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"R19-20260102","doi-asserted-by":"crossref","first-page":"943715","DOI":"10.3389\/fonc.2022.943715","article-title":"Long-term outcome following microwave ablation of lung metastases from colorectal cancer","volume":"12","author":"Han","year":"2022","journal-title":"Front Oncol"},{"key":"R20-20260102","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijsu.2018.03.034","article-title":"Long-term results of CT-guided percutaneous radiofrequency ablation of inoperable patients with stage Ia non-small cell lung cancer:A retrospective cohort study","volume":"53","author":"Huang","year":"2018","journal-title":"Int J Surg"},{"key":"R21-20260102","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1080\/02656736.2021.1902000","article-title":"Risk prediction of pneumothorax in lung malignancy patients treated with percutaneous microwave ablation:Development of nomogram model","volume":"38","author":"Xu","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"R22-20260102","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/02656736.2021.1885755","article-title":"Risk prediction of pleural effusion in lung malignancy patients treated with CT-guided percutaneous microwave ablation:A nomogram and artificial neural network model","volume":"38","author":"Xu","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"R23-20260102","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.athoracsur.2014.03.008","article-title":"Major complications after lung microwave ablation:A single-center experience on 204 sessions","volume":"98","author":"Zheng","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"R24-20260102","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.crad.2015.06.092","article-title":"High-powered microwave ablation of larger hepatocellular carcinoma:Evaluation of recurrence rate and factors related to recurrence","volume":"70","author":"Zhang","year":"2015","journal-title":"Clin Radiol"},{"key":"R25-20260102","doi-asserted-by":"crossref","first-page":"2190065","DOI":"10.1080\/02656736.2023.2190065","article-title":"Exosomal miR-133a-3p promotes the growth and metastasis of lung cancer cells following incomplete microwave ablation","volume":"40","author":"Yang","year":"2023","journal-title":"Int J Hyperthermia"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1047_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:56:57Z","timestamp":1786647417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1047_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1047_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2024-05-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}